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Previewsnutrients act to more slowly alter a spec-
trum of signaling pathways and gene
expression changes, ultimately leading
to depolarization or hyperpolarization.
Furthermore, POMC neurons are much
less homogeneous than the NPY/AgRP
neurons, with only a subset of cells depo-
larized by leptin (Williams et al., 2010).
Data also suggest there may be both
GABAergic and glutamatergic POMC
cells (Hentges et al., 2009). Thus, electrical
stimulation of POMC cells may produce
a more mixed response than the pure
inhibitory GABAergic drive from NPY/
AgRP neurons or the potent anorexigenic
response to a-MSH alone.
Nonetheless,optogenetics is apowerful
new tool to apply to the analysis of the
energy homeostasis circuitry, and the
rapidly developing optogenetic arma-
mentarium includes channels that can
be used to hyperpolarize and inhibit
neurons, channels that can be targeted236 Cell Metabolism 13, March 2, 2011 ª201to presynaptic nerve terminals, and light-
activated molecules that couple to activa-
tion of G protein signaling pathways
(Gradinaru et al., 2010). For illuminating
the role of neurons that are too diffusely
distributed to activate with a fiber-optic
light stimulus, chemical-genetic tools,
such as a G protein-coupled receptor
capable of activating neurons in response
to a pharmacologically inert, orally bio-
available drug, clozapine-N-oxide, have
also been engineered (Alexander et al.,
2009). Given the complexity of the
circuitry involved in energy homeostasis,
optogenetics and chemical-genetic tools
may prove invaluable.REFERENCES
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Insulin contributes to skeletal muscle glucose uptake by increasing blood flow and recruiting perfused capil-
laries. In this issue of Cell Metabolism, Kubota et al. (2011) show that deletion of IRS-2 in endothelial cells in
mice causes impaired transcapillary insulin transport, decreased insulin-stimulated glucose uptake in
muscle, and mild glucose intolerance.Insulin signaling in vascular endothelium
produces at least two types of discrete
actions. First, insulin modifies endothelial
homeostasis in arteries, thereby making
the vascular wall less susceptible to
atherosclerosis (Rask-Madsen and King,
2007). Second, insulin may regulate its
own delivery to skeletal muscle and other
tissues (Barrett et al., 2009; Chiu et al.,
2008). Whether this mechanism contrib-
utes significantly to systemic insulin
sensitivity is not clear in spite of extensive
investigation. In this issue, Kubota et al.
(2011) report that endothelial insulinsignaling through insulin receptor sub-
strate-2 (IRS-2), a docking protein
relaying insulin receptor activation to in-
tracellular signaling, contributes to trans-
capillary insulin transport in muscle and
affects glucose tolerance in mice. These
results suggest that endothelial cell func-
tion may be a therapeutic target for
improving peripheral insulin sensitivity.
The rate of insulin delivery from the
blood to the interstitial space is limited
by transport across the capillary wall in
tissues where endothelial cells form tight
junctions. After binding to its receptors,insulin can be transported across cultured
endothelial cell monolayers by transcyto-
sis (King and Johnson, 1985), but little is
known about intracellular insulin signaling
in this process (Wang et al., 2008). It is
also unclear whether transcytosis (Barrett
et al., 2009) rather than passive diffusion
at cell junctions (Chiu et al., 2008) is
responsible for transendothelial transport
of insulin in vivo, which is important
because transcytosis is more likely to be
a regulated process which can be modi-
fied for therapeutic gain. Insulin resis-
tance developing during high-fat feeding
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Previewsof mice can be detected earlier in endo-
thelium than in other tissues (Kim et al.,
2008), suggesting that early reversal of
endothelial insulin resistance could help
prevent peripheral insulin resistance if
there was a cause-and-effect relationship
between the two.
Kubota et al. (2011) studied mice with
obesity-associated insulin resistance in-
duced by high-fat diet or the ob/obmuta-
tion and found that IRS-1 and IRS-2 in
endothelial cells were downregulated by
50% and 80%, respectively. Capillary
blood volume increased 10 min after start
of a euglycemic hyperinsulinemic clamp
in control mice, followed by an increase
in interstitial insulin concentrations after
60 min. However, in obese mice the
increase in capillary blood volume in skel-
etal muscle was blunted at 10 min, and
interstitial insulin concentrations were
decreased at 60 min, suggesting that
insulin delivery from the blood to the inter-
stitial space was delayed by transport
across the capillary wall during physiolog-
ical conditions, and further delayed in
obesity-associated insulin resistance. To
study whether insulin activates insulin
signaling to facilitate its own transendo-
thelial transport, the authors then created
and studied mice with knockout of IRS-1
or IRS-2 in endothelial cells (ETIrs1KO
and ETIrs2KO mice, respectively).
ETIrs1KO mice were not different than
their controls with respect to endothelial
cell insulin signaling, whole-body insulin
sensitivity, or glucose tolerance, but
ETIrs2KO mice had similar defects in
increases of capillary blood volume and
interstitial insulin concentrations as mice
with obesity-associated insulin resis-
tance. In addition, ETIrs2KO mice had
glucose intolerance relative to their
controls. If a similar mechanism exists in
humans, it would be a new target for
insulin-sensitizing drugs.
Insulin-stimulated increases in blood
flow and increased recruitment of
perfused capillaries are both dependent
on nitric oxide (NO) production and may
augment insulin delivery to the intersti-
tium. Because NO has been shown to
mediate insulin-stimulated capillary
recruitment, Kubota et al. (2011) treated
ETIrs2KO mice with beraprost sodium,
a prostacyclin analog which increases
eNOS expression. In ETIrs2KO mice, this
treatment increased eNOS protein levels
in endothelial cells and completelynormalized capillary recruitment, intersti-
tial insulin concentrations, and whole-
body insulin sensitivity. Beraprost sodium
had no effect in eNOS knockout mice,
making it unlikely that this effect was
mediated by effects of prostacyclin
directly on skeletal muscle perfusion.
Glucose intolerance in ETIrs2KO mice
was mild, similar to that described for
eNOS knockout mice (Duplain et al.,
2001), and much less severe than in
mice fed a high-fat diet. In the study by
Kubota et al. (2011), plasma glucose
levels measured 30 min after glucose
administration were approximately
180 mg/dl higher in high-fat-fed mice but
only 40 mg/dl higher in ETIrs2KO mice,
compared with controls. This was partly
explained by a maintained ability in
ETIrs2KO mice to reduce endogenous
glucose production from the liver in
response to insulin, an effect that was
profoundly impaired in mice after high-
fat feeding. This abnormality of whole-
body glucose metabolism contrasted
with a considerable impairment of
glucose uptake in skeletal muscle during
a euglycemic hyperinsulimic clamp.
These experiments show that insulin
signaling through IRS-2 in endothelial
cells is important for insulin delivery to
skeletal muscle interstitium and insulin-
stimulated glucose uptake in muscle, but
has little effect on whole-body glucose
tolerance when insulin sensitivity in the
liver is normal. Whether the contribution
of endothelial insulin resistance to
whole-body glucose intolerance is more
pronounced when insulin signaling in the
liver is impaired, as in human insulin resis-
tance, remains to be determined.
The results of Kubota et al. (2011) are
somewhat at odds with a previous study
in mice with the insulin receptor deleted
in endothelial cells (Vicent et al., 2003).
These animals were glucose tolerant
except when challenged with diets with
abnormal sodium content. However,
when cross-bred with atherosclerosis-
susceptible apolipoprotein E (apoE) null
mice, atherosclerotic lesion area in the
aorta and carotid artery was increased
by up to 2.9-fold (Rask-Madsen et al.,
2010). Glucose and insulin tolerance,
plasma lipids, and blood pressure were
not different in the two groups, and the
increased atherosclerosis susceptibility
could not be recapitulated by transplanta-
tion of bone marrow from insulin receptorCell Metabolismknockout mice (Rask-Madsen et al.,
2010), showing that the phenotype was
due to an isolated defect in endothelial
cell insulin signaling. Therefore, loss of
insulin action in endothelial cells in this
model had a large impact on atheroscle-
rosis development, but no effect on
glucose tolerance (Rask-Madsen et al.,
2010).
Kubota et al. (2011) speculate that
selective impairment of the phosphatidyli-
nositol 3-kinase (PI3K) pathway of insulin
signaling, which is activated by IRS
proteins, has a larger effect on insulin
sensitivity in muscle than deletion of all
insulin signaling (Vicent et al., 2003;
Rask-Madsen et al., 2010) because acti-
vation of the PI3K and Erk pathway of
insulin signaling can have opposite hemo-
dynamic effects. In addition to this ques-
tion, it is unresolved whether the blunted
increase in interstitial insulin concentra-
tions during hyperinsulinemia in ETIrs2KO
mice is due to a blunted increase in
capillary surface area, or a defect in
a mechanism by which transendothelial
insulin transport is regulated by endothe-
lial cell insulin signaling, with impaired
capillary recruitment as an associated
(or contributing) factor. Future challenges
include determining whether the mecha-
nisms impairing insulin signaling in
obesity and type 2 diabetes are the
same in endothelial cells as in classical
insulin-sensitive tissues like muscle.
Discoveries in this field may provide
targets for augmenting endothelial insulin
sensitivity which may not only improve
muscle insulin sensitivity but also help
prevent long-term complications like
atherosclerosis in people with the meta-
bolic syndrome or diabetes.REFERENCES
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An understanding of the full powers of brown adipose tissue (BAT) is only successively being accumulated. In
a paper inNatureMedicine, Bartelt et al. (2011) add further impressive aspects to the potential powers of BAT
in the combat against the metabolic syndrome by demonstrating its vast capacity for triglyceride clearance
and glucose disposal.Until very recently, brown adipose tissue
(BAT) seemed to attract interest from
only a few hibernation researchers and
mitochondrial bioenergeticists. This was
understandable. BAT is not easily discern-
able: It has a color and texture that blends
into both fat and muscle, and it is found in
small depots spread out in different parts
of the body, totally amounting to only
a small percentage of total body weight
(Figure 1A). Yet this organ has the power
to be a main player in metabolism. In their
recent study in Nature Medicine, Bartelt
et al. (2011) reveal new major roles for
BAT in blood triglyceride clearance and
glucose disposal.
To generate heat for thermogenesis,
BAT first uses its stored lipid as substrate
(Figure 1B). This early phase of thermo-
genesis corresponds molecularly to
norepinephrine released from the sympa-
thetic nerves activating the release of free
fatty acids from triglyceride droplets
(Figure 1B). Some of these fatty acids
activate UCP1 (uncoupling protein 1).
The remaining fatty acids are imported
into the mitochondria and combusted,
releasing energy as heat, due to UCP1
action. However, with brown fat
comprising such a small percent of total
body weight, the stored lipid can sustain
thermogenesis for only a short time, andfurther energy supplies must come from
outside the tissue.
The study of Bartelt et al. (2011) reveals
the ability of BAT to import and combust
triglycerides from the circulation and
demonstrates how this uptake delivers
substrate for continued thermogenesis.
By exposing mice to cold, Bartelt et al.
optimized the acute activity of BAT, and
this had dramatic effects on triglyceride
levels in the blood. Specifically, plasma
triglycerides (mainly in the form of chylo-
microns, i.e., the dietary fat) practically
disappeared from the circulation—not
because fewer chylomicrons were
formed, but because they were nearly all
cleared by BAT; in fact, nearly half of the
triglyceride from a meal ended up in BAT
(Figure 1C). The clearance capacity of
BAT could probably be even higher: prior
to being exposed to cold, the mice had
been living at normal environmental
temperature and would thus have to also
shiver in the cold (explaining the fatty
acid uptake in the muscles). Had cold-
acclimated mice with recruited BAT
been used, the fraction entering BAT
may have been even higher.
The data of Bartelt et al. lead to the
following scenario for the high triglyceride
clearance into BAT (Figure 1D). While
norepinephrine activates the release offree fatty acids from triglyceride droplets
within the brown fat cell, it also induces
VEGF (Fredriksson et al., 2005) and lipo-
protein lipase (LPL) gene expression
(Mitchell et al., 1992; Bartelt et al., 2011).
VEGF leads to increased capillary perme-
ability, allowing plasma triglycerides to
leave the capillaries (as elegantly video-
recorded in vivo by Bartelt et al.). LPL
degrades the triglycerides and allows
fatty acids to become available for
combustion in the tissue through the
action of the plasma membrane trans-
porter CD36; without CD36, the mice
could not fight the cold.
In addition to BAT being a major lipid-
combusting tissue, Bartelt et al. also point
to BAT as being a major organ for glucose
disposal, as (particularly in obese mice)
a large fraction of ingested glucose is
channeled to BAT (Figure 1E), where the
glucose, just like lipids, will be com-
busted. This result reinforces the obser-
vation that BAT is an avid glucose uptake
organ (Cawthorne, 1989). Indeed, the
present realization that adult humans
possess active BAT initially arose from
the unexpected observations, made by
radiologists using glucose uptake to
search for tumors, of highly active glucose
uptake into areas that turned out to be
BAT (Hany et al., 2002). Most of the high
